OrganiGram Holdings Inc (OGI) - Net Assets
Based on the latest financial reports, OrganiGram Holdings Inc (OGI) has net assets worth CA$369.46 Million CAD (≈ $267.26 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$530.67 Million ≈ $383.88 Million USD) and total liabilities (CA$161.22 Million ≈ $116.62 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of OrganiGram Holdings Inc to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CA$369.46 Million |
| % of Total Assets | 69.62% |
| Annual Growth Rate | 66.51% |
| 5-Year Change | -27.24% |
| 10-Year Change | 688.81% |
| Growth Volatility | 8503.96 |
OrganiGram Holdings Inc - Net Assets Trend (2012–2025)
This chart illustrates how OrganiGram Holdings Inc's net assets have evolved over time, based on quarterly financial data. Also explore OGI total asset value for the complete picture of this company's asset base.
Annual Net Assets for OrganiGram Holdings Inc (2012–2025)
The table below shows the annual net assets of OrganiGram Holdings Inc from 2012 to 2025. For live valuation and market cap data, see OrganiGram Holdings Inc (OGI) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | CA$349.13 Million ≈ $252.56 Million |
+14.10% |
| 2024-09-30 | CA$305.99 Million ≈ $221.35 Million |
+12.65% |
| 2023-09-30 | CA$271.62 Million ≈ $196.49 Million |
-46.54% |
| 2022-09-30 | CA$508.06 Million ≈ $367.52 Million |
+5.89% |
| 2021-09-30 | CA$479.81 Million ≈ $347.08 Million |
+60.19% |
| 2020-09-30 | CA$299.53 Million ≈ $216.67 Million |
-8.40% |
| 2019-09-30 | CA$327.01 Million ≈ $236.55 Million |
+77.15% |
| 2018-09-30 | CA$184.59 Million ≈ $133.53 Million |
+122.32% |
| 2017-09-30 | CA$83.03 Million ≈ $60.06 Million |
+87.60% |
| 2016-09-30 | CA$44.26 Million ≈ $32.02 Million |
+463.53% |
| 2015-09-30 | CA$7.85 Million ≈ $5.68 Million |
+31964.23% |
| 2014-09-30 | CA$24.50K ≈ $17.72K |
-90.71% |
| 2013-09-30 | CA$263.80K ≈ $190.83K |
-42.88% |
| 2012-09-30 | CA$461.87K ≈ $334.11K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to OrganiGram Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 60850842400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | CA$919.91 Million | 263.49% |
| Other Comprehensive Income | CA$37.95 Million | 10.87% |
| Total Equity | CA$349.13 Million | 100.00% |
OrganiGram Holdings Inc Competitors by Market Cap
The table below lists competitors of OrganiGram Holdings Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hawesko Holding AG
XETRA:HAW
|
$188.69 Million |
|
Sinphar Pharmaceutical Co Ltd
TW:1734
|
$188.76 Million |
|
Ajinomoto Malaysia Bhd
KLSE:2658
|
$188.97 Million |
|
AMA Group Limited
F:KC7
|
$189.11 Million |
|
Gaon Group Ltd
TA:GAGR
|
$188.63 Million |
|
Frauenthal Holding AG
VI:FKA
|
$188.60 Million |
|
Repro Med Systems Inc
NASDAQ:KRMD
|
$188.53 Million |
|
Starrag Group Holding AG
SW:STGN
|
$188.48 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in OrganiGram Holdings Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 305,989,000 to 349,130,000, a change of 43,141,000 (14.1%).
- Net loss of 24,759,000 reduced equity.
- Share repurchases of 41,185,000 reduced equity.
- New share issuances of 41,181,000 increased equity.
- Other comprehensive income increased equity by 883,000.
- Other factors increased equity by 67,021,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CA$-24.76 Million | -7.09% |
| Share Repurchases | CA$41.19 Million | -11.8% |
| Share Issuances | CA$41.18 Million | +11.8% |
| Other Comprehensive Income | CA$883.00K | +0.25% |
| Other Changes | CA$67.02 Million | +19.2% |
| Total Change | CA$- | 14.10% |
Book Value vs Market Value Analysis
This analysis compares OrganiGram Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.71x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 7.30x to 0.71x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-09-30 | CA$0.26 | CA$1.93 | x |
| 2013-09-30 | CA$0.13 | CA$1.93 | x |
| 2014-09-30 | CA$0.01 | CA$1.93 | x |
| 2015-09-30 | CA$0.60 | CA$1.93 | x |
| 2016-09-30 | CA$3.02 | CA$1.93 | x |
| 2017-09-30 | CA$0.85 | CA$1.93 | x |
| 2018-09-30 | CA$5.82 | CA$1.93 | x |
| 2019-09-30 | CA$9.28 | CA$1.93 | x |
| 2020-09-30 | CA$1.68 | CA$1.93 | x |
| 2021-09-30 | CA$7.49 | CA$1.93 | x |
| 2022-09-30 | CA$6.58 | CA$1.93 | x |
| 2023-09-30 | CA$3.34 | CA$1.93 | x |
| 2024-09-30 | CA$3.21 | CA$1.93 | x |
| 2025-09-30 | CA$2.73 | CA$1.93 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently OrganiGram Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -7.09%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -9.55%
- • Asset Turnover: 0.46x
- • Equity Multiplier: 1.61x
- Recent ROE (-7.09%) is above the historical average (-96.39%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | -30.35% | 0.00% | 0.00x | 1.09x | CA$-186.35K |
| 2013 | -142.24% | 0.00% | 0.00x | 1.28x | CA$-401.63K |
| 2014 | -975.71% | -294.72% | 0.58x | 5.71x | CA$-241.45K |
| 2015 | -16.26% | -129.42% | 0.07x | 1.80x | CA$-2.06 Million |
| 2016 | 1.91% | 13.82% | 0.11x | 1.22x | CA$-3.58 Million |
| 2017 | -13.11% | -202.06% | 0.06x | 1.12x | CA$-19.19 Million |
| 2018 | 11.11% | 165.04% | 0.04x | 1.64x | CA$2.05 Million |
| 2019 | -2.92% | -11.87% | 0.19x | 1.31x | CA$-42.24 Million |
| 2020 | -45.46% | -156.87% | 0.21x | 1.39x | CA$-166.11 Million |
| 2021 | -27.24% | -165.11% | 0.14x | 1.15x | CA$-178.68 Million |
| 2022 | -2.81% | -9.80% | 0.25x | 1.14x | CA$-65.09 Million |
| 2023 | -84.48% | -153.80% | 0.50x | 1.10x | CA$-256.64 Million |
| 2024 | -14.85% | -28.43% | 0.39x | 1.33x | CA$-76.04 Million |
| 2025 | -7.09% | -9.55% | 0.46x | 1.61x | CA$-59.67 Million |
Industry Comparison
This section compares OrganiGram Holdings Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $739,937,582
- Average return on equity (ROE) among peers: -40.74%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| OrganiGram Holdings Inc (OGI) | CA$369.46 Million | -30.35% | 0.44x | $188.68 Million |
| Aurora Cannabis Inc (ACB) | $601.87 Million | -11.52% | 0.39x | $193.63 Million |
| Amotiv Limited (AOV) | $915.11 Million | 1.59% | 0.43x | $553.67 Million |
| Aequus Pharmaceuticals Inc (AQS) | $-4.29 Million | 0.00% | 0.00x | $479.73K |
| Avicanna Inc (AVCN) | $841.07K | -309.08% | 1.52x | $13.17 Million |
| Avant Brands Inc (AVNT) | $-490.96K | 0.00% | 0.00x | $4.13 Million |
| Bausch Health Companies Inc (BHC) | $5.23 Billion | -16.55% | 4.34x | $2.06 Billion |
| CanadaBis Capital Inc (CANB) | $150.00K | 0.00% | 0.00x | $1.53 Million |
| Cannabist Company Holdings Inc (CBST) | $550.08 Million | -25.79% | 1.50x | $12.59 Million |
| Cipher Pharmaceuticals Inc (CPH) | $80.52 Million | 25.31% | 0.07x | $326.62 Million |
| Cardiol Therapeutics Inc Class A (CRDL) | $22.27 Million | -71.36% | 0.11x | $148.65 Million |
About OrganiGram Holdings Inc
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Ediso… Read more